@article{c0f2dbaedca743cca712ee55acfe34a3,
title = "The long road to TRAIL therapy: A TRAILshort detour",
keywords = "Anti-apoptosis, Apoptosis, Cancer therapy, TRAIL, TRAILshort",
author = "Chandrasekar, {Aswath P.} and Mark Maynes and Badley, {Andrew D.}",
note = "Funding Information: Authors have no conflicts of interest to declare. ADB is supported by grants from NIAID (grants AI110173 and AI120698) Amfar (#109593) and Mayo Clinic (HH Shieck Khalifa Bib Zayed Al-Nahyan Named Professorship of Infectious Diseases). ADB is a paid consultant for Abbvie and Flambeau Diagnostics, is a paid member of the DSMB for Corvus Pharmaceuticals, Equilium, and Excision Biotherapeutics, has received fees for speaking for Reach MD, owns equity for scientific advisory work in Zentalis and Nference, and is founder and President of Splissen therapeutics.",
year = "2021",
month = mar,
day = "1",
language = "English (US)",
volume = "12",
pages = "589--591",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "7",
}